Skip to main content
Signal8

AURORA CANNABIS INC (ACB)

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc. logo

Aurora Cannabis Inc.

NASDAQ:ACBHealthcare
+0.00%$4.40
Mkt Cap$289.28M
EV-
Float65.43M
O/S65.75M
VOL116K sh
$ Vol$508K
RVOL0.06×
Inst Own11.5%
SI12.9%
Net Cash/Sh-
Dilution
Aurora Cannabis Inc. logoNASDAQ:ACB$4.40+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 19, 20264.404.434.334.40116,048
Nov 18, 20264.524.584.384.40934,119
Nov 17, 20264.594.624.494.52830,490
Nov 16, 20264.884.914.474.612,812,255
Nov 13, 20264.985.034.874.941,436,307
Nov 12, 20265.005.104.984.991,996,549
Nov 11, 20265.105.105.055.05699,158
Nov 10, 20265.145.295.095.111,431,170
Nov 9, 20265.255.305.155.161,910,244
Nov 6, 20265.105.245.085.242,087,937
Nov 5, 20265.205.305.055.195,130,951
Nov 4, 20265.165.265.105.243,182,560
Nov 3, 20264.715.204.715.169,011,563
Nov 2, 20264.164.344.094.222,040,424
Oct 30, 20264.034.093.984.06807,143
Oct 29, 20264.054.144.044.08509,991
Oct 28, 20264.094.103.984.08555,462
Oct 27, 20263.904.163.904.15579,159
Oct 26, 20263.853.953.843.90494,669
Oct 23, 20263.963.963.873.88602,877
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
3
HOLD
8
SELL
3
TOTAL14
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
11.5%
Institutional
(161)
0.0%
Insiderⓘ
(0)
4.9%
5%+ Owners
(1)
83.5%
Unattributed (incl. retail)ⓘ
Institutional11.5%
5%+ Beneficial4.9%
Unattributed (incl. retail)83.5%
Sources: 13F, 13D/13GO/S: 65.7M · as of 4 Nov 2026 · SEC filings
Insiders & Institutional Holders
About

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers.

The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach.

Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC.

The company's main corporate office is located in Edmonton, Canada.

Key Metrics
Market Cap$289.28M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership11.55%

based on 65.75M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
CountryCACA
IPO DateJul 15, 2014
Shares Outstanding65.75M
Authorized Shares
Float65.43M
52-Week Range
$2.56$6.36
$4.40(48th percentile)
Volume
Average Daily Volume1.76M
115.46K today vs 1.76M avg(-93%)

30d Avg

1.76M

60d Avg

1.45M

90d Avg

1.31M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Signal8's dilution snapshot of ACB as of Mar 31, 2026 records an effective F-10 shelf registration (effective Feb 14, 2025), an at-the-market sales agreement dated Feb 4, 2026 and an ATM sale closed Aug 18, 2026, from SEC filings. Aurora Cannabis Inc. (NASDAQ: ACB) traded at $4.40 on Nov 19, 2026, unchanged from the previous close of $4.40. 52-week range: $2.56 to $6.36. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).